Systolic blood pressure in heart failure with preserved ejection fraction treated with sacubitril/valsartan
… of chronic heart failure. Dr. Anand has received fees for serving on a Steering Committee
from AstraZeneca, ARCA Biopharma, Amgen, and LivaNova; has received fees for serving as …
from AstraZeneca, ARCA Biopharma, Amgen, and LivaNova; has received fees for serving as …
Sacubitril/valsartan is well tolerated in patients with longstanding heart failure and history of cancer and improves ventricular function: real-world data
MK Frey, H Arfsten, N Pavo, E Han, S Kastl… - Cardio-oncology, 2021 - Springer
… heart failure therapy when adding sacubitril/valsartan even in already longterm chronic heart
failure … with sacubitril/valsartan appears to address many causes of heart failure induced by …
failure … with sacubitril/valsartan appears to address many causes of heart failure induced by …
Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
P Pericas, C Mas-Lladó, MF Ramis-Barceló… - High Blood Pressure & …, 2021 - Springer
… chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart
failure of … Developed with the special contribution of the Heart Failure Association (HFA) of …
failure of … Developed with the special contribution of the Heart Failure Association (HFA) of …
Sacubitril/valsartan induces global cardiac reverse remodeling in long-lasting heart failure with reduced ejection fraction: standard and advanced echocardiographic …
M Castrichini, P Manca, V Nuzzi, G Barbati… - Journal of Clinical …, 2020 - mdpi.com
… chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from …
A Peikert, M Vaduganathan… - … of Heart Failure, 2022 - Wiley Online Library
… Diabetes is associated with a faster rate of renal function decline in patients with heart failure
(HF). Sacubitril/valsartan attenuates the deterioration of renal function to a greater extent in …
(HF). Sacubitril/valsartan attenuates the deterioration of renal function to a greater extent in …
Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction
GB Bolla, A Fedele, A Faggiano, C Sala… - BMC Cardiovascular …, 2022 - Springer
… chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
heart failure … Developed with the special contribution of the Heart Failure Association (HFA) of …
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter …
MC Pastore, GE Mandoli, A Giannoni… - European Heart …, 2022 - academic.oup.com
… Heart failure with reduced ejection fraction (HFrEF) is a multifactorial cardiovascular … due
to cardiovascular causes, such as heart failure (HF) decompensation or malignant ventricular …
to cardiovascular causes, such as heart failure (HF) decompensation or malignant ventricular …
Pulse pressure, prognosis, and influence of sacubitril/valsartan in heart failure with preserved ejection fraction
… Heart Association functional classes II to IV, structural heart … of both valsartan (80 mg twice
daily) and sacubitril/valsartan (… with valsartan 160 mg twice daily or sacubitril/valsartan 97/103 …
daily) and sacubitril/valsartan (… with valsartan 160 mg twice daily or sacubitril/valsartan 97/103 …
Atrial natriuretic peptide and treatment with sacubitril/valsartan in heart failure with reduced ejection fraction
SP Murphy, MF Prescott, A Camacho, SR Iyer… - Heart failure, 2021 - jacc.org
… change in atrial natriuretic peptide (ANP) and reverse cardiac remodeling following
initiation of sacubitril/valsartan in patients with heart failure with reduced ejection fraction (HFrEF). …
initiation of sacubitril/valsartan in patients with heart failure with reduced ejection fraction (HFrEF). …
Effect of sacubitril-valsartan vs enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial
… -valsartan reduces cardiovascular mortality and heart failure hospitalization in patients
with heart failure and … Objective To determine whether treatment of HFrEF with sacubitril-valsartan …
with heart failure and … Objective To determine whether treatment of HFrEF with sacubitril-valsartan …